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To examine the relationship between symptoms of insomnia and sleep duration and inci-
dent total (non-fatal plus fatal) strokes, non-fatal strokes, and fatal strokes in a large cohort
of men and women from the general population in Germany.
Methods
In four population-based MONICA (monitoring trends and determinants in cardiovascular
disease)/KORA (Cooperative Health Research in the Region of Augsburg) surveys con-
ducted between 1984 and 2001, 17,604 men and women (aged 25 to 74 years) were asked
about issues like sleep, health behavior, and medical history. In subsequent surveys and
mortality follow-ups, incident stroke cases (cerebral hemorrhage, ischemic stroke, transient
ischemic attack, unknown stroke type) were gathered prospectively until 2009. Sex-specific
hazard ratios (HR) and their 95% confidence intervals (CI) were estimated using sequential
Cox proportional hazards regression models.
Results
During a mean follow-up of 14 years, 917 strokes (710 non-fatal strokes and 207 fatal
strokes) were observed. Trouble falling asleep and difficulty staying asleep were not signifi-
cantly related to any incident stroke outcome in either sex in the multivariable models.
Among men, the HR for the association between short (5 hours) and long (10 hours)
daily sleep duration and total strokes were 1.44 (95% CI: 1.01–2.06) and 1.63 (95% CI:
1.16–2.29), after adjustment for basic confounding variables. As for non-fatal strokes and
fatal strokes, in the analyses adjusted for age, survey, education, physical activity, alcohol
consumption, smoking habits, body mass index, hypertension, diabetes, and dyslipidemia,
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the increased risks persisted, albeit somewhat attenuated, but no longer remained signifi-
cant. Among women, in the multivariable analyses the quantity of sleep was also not related
to any stroke outcome.
Conclusion
In the present study, symptoms of insomnia and exceptional sleep duration were not signifi-
cantly predictive of incident total strokes, non-fatal strokes, and fatal strokes in either sex.
Introduction
Strokes are one of the leading causes of severe disability [1], morbidity [2], and mortality [3]
worldwide. According to estimates from the Global Burden of Disease Study, 16.9 million indi-
viduals suffered a first stroke in the year 2010. In the same year, 5.9 million stroke-related
deaths occurred [4]. Besides the serious effects for the individuals concerned, their families,
and their friends, strokes can cause considerable societal costs. For Germany, projections up to
the year 2025 yielded expected direct costs of 108.6 billion EUR for first ischemic strokes alone
[5].
The probability of suffering a stroke increases with age [6]. Due to the almost worldwide
trend of aging populations [7], it is estimated that the number of individuals suffering from a
stroke will continue to increase in the future. Various studies have demonstrated that primary
prevention, for instance, living a healthy lifestyle, can reduce the risk of strokes [8–10]. There-
fore, identifying modifiable risk factors is of particular interest to raise general awareness so
that, ideally, preventive measures can be undertaken. Although there have been many advances
in determining various stroke-related risk factors [8, 9], there are differing results regarding
disturbed sleep [11, 12]. Moreover, whereas short and long sleep duration is well established as
a risk factor for all-cause mortality [13], the association between exceptional sleep duration
and stroke-related mortality is less clear [14].
Symptoms of insomnia, such as trouble falling asleep and difficulty staying asleep, affect
approximately one-third of the German general population [15] and seem to be one of the
most frequent health-related complaints in adults [16]. Sleep is an important factor for biologi-
cal recovery functions [17]. Sleep deprivation has been shown to be associated with increased
heart rate and decreased heart rate variability [18], raised inflammatory and proinflammatory
markers [19], and the shortening of telomere length [20]. In addition, short sleep duration is
related to unhealthy behavior, for example, the preference of energy-rich food and an increased
number of meals [21], while on the other hand long sleep duration was found to be associated
with poor physical and mental health [22]. All these factors might be linked to an increased
risk of strokes. Thus, it could be hypothesized that symptoms of insomnia, as well as excep-
tional sleep duration, can be related to the incidence of strokes.
Therefore, the primary aim of this study was to investigate the influence of trouble falling
asleep, difficulty staying asleep, and short and long sleep duration on the risk of developing
strokes (non-fatal plus fatal) in men and women from the general population in Germany. As
there is some evidence that the underlying mechanisms of developing a stroke, as opposed to
dying from a stroke, might be different [23] and also for reasons of better comparability with
previous research, a secondary goal was to examine whether the diverse sleep issues have differ-
ent effects on suffering non-fatal strokes or fatal strokes, separately.
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Methods
Study design and participants
The present post-hoc analyses were performed using data from the prospective, population-
based cohort study, Monitoring Trends and Determinants in Cardiovascular Diseases (MON-
ICA)/Cooperative Health Research in the Region of Augsburg (KORA) (details of the projects
have been described previously [24–26]).
In brief, four independent cross-sectional surveys were conducted in 1984/85 (Survey (S) 1),
1989/90 (S2), 1994/95 (S3), and 1999/2001 (S4) among the general population of the region of
Augsburg, Southern Germany. If an individual was chosen randomly for participation in more
than one survey, only data from the respective baseline survey was considered for the analyses.
Altogether, 17,604 individuals aged 25 to 74 years participated in at least one of the four sur-
veys (response between 68% and 79%) [25–27]. Follow-up activities, including assessment of
the vital status of the participants, causes of deaths, and incident diseases [26], were carried out
until 2009.
Included in the analyses were data from participants who had not experienced a stroke
prior to the baseline survey, with available information about the presence or absence of non-
fatal strokes or fatal strokes during the follow-up period (n = 16,280). Data from 533 partici-
pants were excluded because of missing values in one or more of the variables required for the
multivariable analyses (symptoms of insomnia: 25 missing values; other variables: 508 missing
values). Thus, the final data set for analyses regarding symptoms of insomnia consisted of
7,911 men and 7,835 women aged 25 to 74 years. Owing to the fact that in the last survey (S4)
information about sleep duration was not obtained, the basis for the analyses concerning the
duration of average daily sleep was 6,157 men and 5,974 women in the same age range (sleep
duration variable: 5 missing values).
The MONICA/KORA Augsburg Cohort Study was approved by the ethics committee of the
Bavarian Medical Association (“Bayerische Landesärztekammer”) and the performances were
realized in accordance with the Declaration of Helsinki. All individuals whose data were
included in the analyses gave their written informed consent to taking part in the study and to
having the information provided used for scientific purposes.
Outcome variables
The study has the following three endpoints of interest: the respective first occurrences of 1)
total (non-fatal plus fatal) strokes, 2) non-fatal strokes, and 3) fatal strokes from the time point
of the baseline examination until the end of the follow-up on December 31, 2009.
Non-fatal strokes were assessed by asking “Have you ever had a stroke diagnosed by a physi-
cian?” in regular face-to-face interviews and postal surveys. Using data from participants’ hos-
pital records and information gathered from their attending physicians, all potential stroke
cases and the date of diagnosis were validated. During the validation process, non-fatal strokes
were divided into embolic strokes, ischemic strokes, intracerebral hemorrhage, subarachnoid
hemorrhage, transient ischemic attack/prolonged reversible ischemic neurological deficit, and
unknown stroke type.
To ascertain fatal strokes, the survival status of all participants was regularly checked using
information provided by population registries inside and outside the study area. Death certifi-
cates of deceased participants, preserved by local health authorities, were analyzed and the
main causes of death extracted. As mentioned above, all information regarding fatal strokes
was also checked by screening hospital records. Additionally, all hospital records were also
screened to examine whether an individual who had died from a cause other than a stroke had
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suffered a stroke in the time between baseline/the last follow-up and the participant’s eventual
death. The following three-digit International Classification of Diseases, Ninth Revision (ICD-
9) codes were considered as strokes as cause of death: 430, 431, 433, 434, 436.
Regardless of the types of strokes, for the analyses all strokes were classified in total strokes,
non-fatal strokes, and fatal strokes.
Symptoms of insomnia and sleep duration
Symptoms of insomnia were assessed by self-report in a personal interview at baseline using
two questions regarding trouble falling asleep (“Did you have trouble falling asleep?”) and diffi-
culty staying asleep (“Did you have problems with sleeping through the night?”). Answer cate-
gories were on a Likert scale (often, sometimes, or almost never). To distinguish milder forms
of disturbed sleep from more severe cases, both variables were binary coded, whereby partici-
pants were categorized as having a certain symptom of insomnia if they chose “often”and as
having no difficulties if they chose “sometimes” or “almost never” as their response. Sleep dura-
tion was ascertained by using the question ‘‘How many hours a day do you usually sleep?”. The
participants were encouraged to answer in whole numbers. As in former studies [28, 29], sleep
duration was categorized in5, 6, 7–8 (reference), 9, or10 hours of daily sleep.
Covariables
Baseline information about socio-demographic characteristics, lifestyle behavior, and health
status of the study participants was obtained using self-administered questionnaires and face-
to-face interviews by trained medical staff. The educational level of the participants was esti-
mated by years of education,11 years being classified as low educational level and>11 years
as high educational level. Employment status was categorized as currently employed (full- or
part-time) or unemployed. Physical activity during leisure time was assessed with a question
concerning leisure-time sport activity in winter and in summer, respectively. Responses to
these two questions were combined to illustrate the level of leisure-time physical activity (very
active, moderately active, not very active, no sport [30]). For average daily alcohol consump-
tion, sex-specific cut-off points were applied (0–39 and40 grams (g) alcohol for men; 0–19
and20 g alcohol for women) [31]. Participants were classified as current cigarette smoker
(occasionally or regularly) or nonsmoker (individuals who had quit smoking previously or
who had never smoked). History of physician-diagnosed diabetes and myocardial infarction
were assessed by self-report. Angina pectoris was obtained using the categorization from Rose
et al. [32]. Depressed mood was measured by means of the DEpression and EXhaustion scale
(DEEX scale), a subscale of the von Zerssen checklist [33, 34]. Values ranged from 0 to 24, with
higher values indicating a higher level of depressive symptomatology.
In addition to the extensive interviews, physical examinations were performed using stan-
dardized methods to gather information about baseline body mass index (BMI), dyslipidemia,
and hypertension. To calculate the BMI of the participants, the measured weight in kilograms
was divided by the square of height in meters. Dyslipidemia was defined as a ratio of total cho-
lesterol divided by high-density lipoprotein (HDL) cholesterol5 [25]. Methods used for mea-
suring and analyzing total cholesterol and HDL cholesterol are expounded in detail in, e.g.,
[35] and [25]. Actual hypertension was defined as blood pressure140/90 mmHg and/or the
consumption of antihypertensive medication according to the Subcommittee of the World
Health Organization and the International Society of Hypertension (WHO-ISH) [36], given
that the participants were aware of being hypertensive. Blood pressure was measured with a
random-zero sphygmomanometer in S1-S3 (Hawksley & Sons Ltd, Lancing, England) [37] and
by use of an oscillometric digital blood pressure monitor (HEM-705CP, Omron Corporation,
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Tokyo, Japan) in S4 [38] in a sitting position. Antihypertensives that had been consumed during
the past 7 days before study examination were recorded and classified by agents following the
anatomic-therapeutic-chemical classification system. Antihypertensives were defined as any
medication recommended by the German League for the Control of Hypertension (recently Ger-
man Hypertension League) to lower the blood pressure (http://www.hochdruckliga.de; in the
respective applicable version).
Statistical analyses
The description of the baseline characteristics of the study participants was based on calcula-
tions of relative frequencies for categorical variables, means with corresponding standard devi-
ations for normally distributed continuous variables, and medians with interquartile ranges for
skewed data. Depending on the categorization of the variables and distribution of the data, dif-
ferences were tested using chi-square test, Student’s t test, or Mann-Whitney U test stratified
for men and women.
To predict the effect of the three sleep variables (trouble falling asleep, difficulty staying
asleep, and sleep duration) on the risk of the first occurrence of the diverse stroke outcomes
(total strokes, non-fatal strokes, and fatal strokes), four nested semi-parametric Cox propor-
tional hazards regression models were estimated for each sleep variable [39].
Observation time was determined as starting at the time of baseline examination (S1-S4)
and continued until date of stroke diagnosis, time of death (caused by a stroke or from a cause
other than a stroke), time of last participation in one follow-up study, or the end of follow-up
on December 31, 2009. For all participants for whom no follow-up was possible (e.g., prohibi-
tion of contact, unknown address), the values of the incident stroke variables were coded as
missing. If the validation of potential stroke cases was not possible, participants were censored
to an earlier time point. If this was not possible either, the values of the stroke variables were
programmed as missing.
For analyses with non-fatal strokes as the outcome of interest, data from all participants
with fatal strokes were excluded. The same procedure was carried out to examine fatal strokes
as the dependent variable. Potential confounders were preselected based on the results of a
prior literature review and bivariate associations with the stroke variables (p-value0.2). All
remaining covariables with significant associations were tested for interrelationships and for
multicollinearity. More robust regression models were achieved by excluding the variables
“employment status” and “heart symptoms/disease” owing to their lack of significance in the
multivariable models in any stroke outcome. No violation of the proportional hazards assump-
tion was assumed, because Schoenfeld residuals were independent of time and functions of
time [40].
Four sequential models were estimated separately for each of the three sleep variables (trou-
ble falling asleep, difficulty staying asleep, and sleep duration). Each of the first models (crude
models) contained just one of the respective sleep variables. The second models (basic models)
were, in addition to the models 1, adjusted for sex (men, women), age (continuous), and survey
(1, 2, 3, 4). The third models (socio-demographic and lifestyle models) further included educa-
tion (low, high), leisure-time physical activity level (very active, moderately active, not very
active, no sport), alcohol consumption (men: 0–39 g/day,40 g/day; women: 0–19 g/day,20
g/day), and current smoking activity (yes, no). Finally, the full models (health status models)
were additionally adjusted for BMI (continuous), hypertension (yes, no), diabetes (yes, no),
and dyslipidemia (yes, no).
Estimates were presented as hazard ratios (HR) and their precision as 95% confidence inter-
vals (CI). Interactions between each of the sleep variables and sex were tested; p-values0.2
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were considered to be statistically significant. Because there was evidence of an effect modifica-
tion between sleep duration and sex (p-value = 0.0518), stratified analyses for men and women
were performed.
As indicated in the literature, depressed mood seems to be associated with strokes and sleep
disturbances [14, 41, 42]. Therefore, after the existing models 4 were augmented with the
depressed mood variable, additional analyses were performed to examine its effect. Because the
DEEX scale was not ascertained in survey S4, the analyses were realized with data from the first
three surveys (S1-S3) (missing values in the depressed mood variable: n = 1,191).
Unless otherwise stated, p-values of0.05 were deemed as statistically significant and all
statistical tests were calculated two-tailed. The analyses were performed using the statistics pro-
gram SAS (Statistical Analysis System, version 9.2, SAS Institute Inc., Cary, NC).
Results
Characteristics of study participants
During a mean follow-up time of 14 years, 710 non-fatal strokes (men: 455; women: 255) and
207 fatal strokes (men: 115; women: 92) were observed (crude incidence rate of total strokes:
men: 5.3 per 1,000 person-years; women: 3.1 per 1,000 person-years).
Table 1 provides information about baseline characteristics of the study participants, strati-
fied by the occurrence of an incident total stroke during the follow-up period for men and
women separately.
When compared with participants who did not suffer a first total stroke since the beginning
of the study, individuals of both sexes who experienced a subsequent stroke reported more often
trouble falling asleep and difficulty staying asleep at baseline examination. Men and women
with a short (5 hours) or long (10 hours) usual daily sleep duration also developed more fre-
quently a first total stroke during the study time than participants who slept 7–8 hours daily.
Furthermore, among those who suffered a stroke during the study time, a higher proportion
of the participants were male, and they were on average significantly older than those who did
not. They were more likely to have a lower educational level and were less physically active in
their leisure time. Moreover, they often had a higher BMI and an impaired health status, with,
for example, a higher proportion of hypertension, diabetes, or dyslipidemia.
Symptoms of insomnia and incident strokes
The unadjusted and multivariable adjusted HR for the first occurrence of total strokes, non-
fatal strokes, and fatal strokes since baseline examination by symptoms of insomnia are pre-
sented in Table 2 for men and in Table 3 for women.
Regarding total strokes, significant associations between trouble falling asleep and difficulty
staying asleep occurred in the crude models (models 1), but attenuated to insignificance in mod-
els 2–4 in both sexes. The crude HR for fatal strokes in men who reported trouble falling asleep
and difficulty staying asleep were 1.95 (95% CI: 1.15–3.31) and 1.84 (95% CI: 1.18–2.86); for
women they were 1.90 (95% CI: 1.18–3.07) and 1.56 (95% CI: 0.98–2.49) (models 1). In the mod-
els adjusted for age and survey (models 2), significant associations were no longer observed.
Sleep duration and incident strokes
Table 4 shows the associations between self-reported sleep duration and total strokes, non-fatal
strokes, and fatal strokes for men; Table 5 presents the corresponding results for women.
Total strokes are associated with long daily sleep duration only until model 3 in men.
Among women, in the multivariable analyses (models 2–4), the amount of sleep was not
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related to any stroke outcome. Concerning non-fatal strokes, the relationship with long daily
sleep duration among men remained significant in the basic model (model 2), but not after a
further adjustment for education, physical activity, alcohol consumption, and smoking habits
(model 3). Among men, in the socio-demographic and lifestyle model (model 3), short and
long daily sleep duration was significantly associated with the development of fatal strokes (HR
2.06, 95% CI: 1.05–4.02 and HR 1.97, 95% CI: 1.03–3.77). After an additional adjustment for
BMI, hypertension, diabetes, and dyslipidemia (model 4), this relationship was no longer sig-
nificant (HR 1.89, 95% CI: 0.96–3.73 and HR 1.72, 95% CI: 0.89–3.33).
Additional analyses
In the full models (models 4) additionally adjusted for depressed mood, a significant associa-
tion was found between short sleep duration and fatal strokes (HR 2.29, 95% CI: 1.13–4.65) in
men only (see S1 Table).
Table 1. Prevalence (%) andmean (±standard deviation) of baseline population characteristics by sex and incident total strokes, men and women
aged 25 to 74 years (N = 15,746).
Men Women
Incident total strokes Incident total strokes
Yes No p-value Yes No p-value
(n = 570) (n = 7,341) (n = 347) (n = 7,488)
Socio-demographic and lifestyle characteristics
Age (years) 58.6 (10.5) 47.7 (13.5) < .0001 60.1 (10.1) 47.4 (13.2) < .0001
Low educational level (%) 72.5 61.9 < .0001 88.2 77.3 < .0001
Employed1 (%) 48.3 73.4 < .0001 21.9 48.3 < .0001
Physically active >2 hours/week (%) 17.4 22.9 < .0001 11.0 13.8 < .0001
High consumption of alcohol (%) 33.9 30.4 0.0848 14.7 19.0 0.0442
Currently smoking (%) 29.3 32.2 0.1503 17.3 21.6 0.0582
Health status
Body mass index (kg/m2) 28.5 (3.6) 27.1 (3.7) < .0001 28.2 (4.9) 26.3 (4.9) < .0001
Hypertension (%) 67.5 42.3 < .0001 61.1 30.1 < .0001
History of heart symptoms/disease2 (%) 9.1 5.6 0.0005 8.1 4.3 0.0009
Diabetes (%) 9.8 3.7 < .0001 13.0 2.9 < .0001
Dyslipidemia (%) 52.3 42.4 < .0001 34.6 16.2 < .0001
Depressed mood3 (score 0–24) 9.0 (5.0–12.0) 8.0 (5.0–11.0) 0.0677 9.0 (5.0–13.0) 10.0 (6.0–13.0) 0.1698
Sleep disturbances and sleep duration
Trouble falling asleep (%) 11.9 8.3 0.0032 22.8 16.0 0.0008
Difficulty staying asleep (%) 21.8 15.2 < .0001 27.4 21.4 0.0083
Sleep duration4 (hours per 24 hours) < .0001 0.0155
5 6.7 4.5 4.4 4.2
6 11.6 15.2 16.0 11.9
7–8 64.6 70.8 62.9 71.6
9 9.7 6.1 11.3 8.1
10 7.5 3.5 5.4 4.2
1 Variable was available for 15,742 individuals.
2 Variable was available for 15,732 individuals.
3 Variable was available for 10,945 individuals. Median and interquartile range.
4 Variable was available for 12,131 individuals.
doi:10.1371/journal.pone.0134480.t001
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Discussion
In the presented analyses, no associations were observed between trouble falling asleep or diffi-
culty staying asleep and the risk of developing any stroke outcome in either sex. Among
Table 2. Hazard ratios and 95% confidence intervals for the incidence of total strokes (N = 7,911), non-fatal strokes (N = 7,796), and fatal strokes
(N = 7,456) according to self-reported symptoms of insomnia, men aged 25 to 74 years.
Men Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Trouble falling asleep
Total strokes (n = 681) 1.59 (1.24–2.05) 1.25 (0.97–1.62) 1.21 (0.93–1.56) 1.17 (0.91–1.52)
Non-fatal strokes (n = 521) 1.53 (1.14–2.04) 1.20 (0.90–1.60) 1.16 (0.86–1.54) 1.12 (0.84–1.51)
Fatal strokes (n = 161) 1.95 (1.15–3.31) 1.53 (0.90–2.59) 1.50 (0.88–2.56) 1.44 (0.84–2.48)
Difficulty staying asleep
Total strokes (n = 1241) 1.78 (1.46–2.17) 1.09 (0.89–1.33) 1.09 (0.89–1.33) 1.06 (0.87–1.30)
Non-fatal strokes (n = 991) 1.79 (1.43–2.23) 1.11 (0.88–1.39) 1.11 (0.88–1.39) 1.08 (0.86–1.35)
Fatal strokes (n = 251) 1.84 (1.18–2.86) 1.02 (0.65–1.59) 1.02 (0.66–1.60) 1.00 (0.64–1.56)
Abbreviation: HR: hazard ratio, CI: confidence interval, N: Size of the underlying study population with regard to the particular stroke outcome.
Model 1: crude model (unadjusted).
Model 2: adjusted for age (continuous) and survey (1, 2, 3, 4).
Model 3: “Socio-demographic and lifestyle model” was, in addition to model 2, further adjusted for education (low, high), physical activity (>2 h/week, 1 h/
week (regular), 1 h/week (irregular), no sport), alcohol consumption (men: 0–39 g/day, 40 g/day; women: 0–19 g/day, 20 g/day), current smoking
activity (yes, no).
Model 4: The full model (“health status model”) was, in addition to model 3, adjusted for BMI (continuous), hypertension (yes, no), diabetes (yes, no),
dyslipidemia (yes, no).
1 Number of incident stroke cases.
doi:10.1371/journal.pone.0134480.t002
Table 3. Hazard ratios and 95% confidence intervals for the incidence of total strokes (N = 7,835), non-fatal strokes (N = 7,743), and fatal strokes
(N = 7,580) according to self-reported symptoms of insomnia, women aged 25 to 74 years.
Women Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Trouble falling asleep
Total strokes (n = 791) 1.75 (1.36–2.25) 0.91 (0.70–1.17) 0.90 (0.70–1.16) 0.92 (0.71–1.18)
Non-fatal strokes (n = 571) 1.72 (1.28–2.31) 0.93 (0.69–1.25) 0.91 (0.68–1.23) 0.92 (0.68–1.24)
Fatal strokes (n = 221) 1.90 (1.18–3.07) 0.84 (0.52–1.36) 0.85 (0.52–1.38) 0.86 (0.53–1.39)
Difficulty staying asleep
Total strokes (n = 951) 1.63 (1.29–2.07) 0.85 (0.67–1.09) 0.86 (0.68–1.09) 0.87 (0.68–1.10)
Non-fatal strokes (n = 711) 1.67 (1.27–2.19) 0.89 (0.67–1.17) 0.89 (0.68–1.18) 0.89 (0.68–1.18)
Fatal strokes (n = 241) 1.56 (0.98–2.49) 0.75 (0.47–1.19) 0.75 (0.47–1.19) 0.75 (0.47–1.20)
Abbreviation: HR: hazard ratio, CI: confidence interval, N: Size of the underlying study population with regard to the particular stroke outcome.
Model 1: crude model (unadjusted).
Model 2: adjusted for age (continuous) and survey (1, 2, 3, 4).
Model 3: “Socio-demographic and lifestyle model” was, in addition to model 2, further adjusted for education (low, high), physical activity (>2 h/week, 1 h/
week (regular), 1 h/week (irregular), no sport), alcohol consumption (men: 0–39 g/day, 40 g/day; women: 0–19 g/day, 20 g/day), current smoking
activity (yes, no).
Model 4: The full model (“health status model”) was, in addition to model 3, adjusted for BMI (continuous), hypertension (yes, no), diabetes (yes, no),
dyslipidemia (yes, no).
1 Number of incident stroke cases.
doi:10.1371/journal.pone.0134480.t003
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women, in the multivariable analyses the quantity of sleep was also not related to any stroke
outcome. However, among men, sleeping5 hours or10 hours daily significantly increased
the risk of developing total strokes, non-fatal strokes, and fatal strokes compared to those sleep-
ing 7–8 hours in the unadjusted analyses. These increased risks persisted, albeit somewhat
attenuated, but no longer remained significant after adjustment for a wide range of covariates,
including socio-demographic aspects, health status, several diseases, and medical history.
The relationship between symptoms of insomnia and sleep duration and the development
of strokes has been investigated before [43, 44]. However, many studies had cross-sectional
study designs [45–51], and some others regarded specific populations, for instance, middle-
aged male employees at a Japanese factory [52]. Prospective population-based studies revealed
varying results.
Two studies using Taiwan’s National Health Insurance Research Database found a higher
risk of developing ischemic strokes [53] and total strokes [11] in individuals with insomnia,
Table 4. Hazard ratios and 95% confidence intervals for the incidence of total strokes (N = 6,157), non-fatal strokes (N = 6,048), and fatal strokes
(N = 5,758) according to self-reported sleep duration (hours per 24 hours), men aged 25 to 74 years.
Men Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Total strokes
Sleep duration
5 (n = 341) 1.84 (1.29–2.62) 1.44 (1.01–2.06) 1.41 (0.99–2.01) 1.36 (0.95–1.94)
6 (n = 591) 0.87 (0.66–1.15) 0.93 (0.70–1.23) 0.94 (0.71–1.24) 0.92 (0.70–1.22)
7–8 (n = 3281) 1.00 1.00 1.00 1.00
9 (n = 491) 2.16 (1.60–2.92) 1.14 (0.84–1.54) 1.08 (0.80–1.47) 1.05 (0.78–1.43)
10 (n = 381) 3.25 (2.32–4.55) 1.63 (1.16–2.29) 1.50 (1.06–2.11) 1.38 (0.98–1.94)
Non-fatal strokes
Sleep duration
5 (n = 241) 1.65 (1.09–2.51) 1.35 (0.89–2.05) 1.32 (0.87–2.00) 1.29 (0.85–1.96)
6 (n = 491) 0.90 (0.67–1.22) 0.95 (0.70–1.29) 0.96 (0.71–1.30) 0.95 (0.70–1.29)
7–8 (n = 2621) 1.00 1.00 1.00 1.00
9 (n = 371) 2.07 (1.47–2.92) 1.13 (0.79–1.60) 1.07 (0.76–1.52) 1.05 (0.74–1.49)
10 (n = 271) 2.92 (1.96–4.34) 1.52 (1.02–2.27) 1.38 (0.92–2.06) 1.27 (0.85–1.91)
Fatal strokes
Sleep duration
5 (n = 101) 2.75 (1.41–5.35) 2.04 (1.05–3.98) 2.06 (1.05–4.02) 1.89 (0.96–3.73)
6 (n = 101) 0.73 (0.37–1.42) 0.77 (0.40–1.51) 0.78 (0.40–1.51) 0.76 (0.39–1.48)
7–8 (n = 661) 1.00 1.00 1.00 1.00
9 (n = 121) 2.69 (1.45–4.98) 1.13 (0.60–2.10) 1.09 (0.58–2.03) 1.02 (0.54–1.91)
10 (n = 111) 4.77 (2.52–9.06) 1.97 (1.03–3.77) 1.97 (1.03–3.77) 1.72 (0.89–3.33)
Abbreviation: HR: hazard ratio, CI: confidence interval, N: Size of the underlying study population with regard to the particular stroke outcome, h: hour.
Model 1: crude model (unadjusted).
Model 2: adjusted for age (continuous) and survey (1, 2, 3, 4).
Model 3: “Socio-demographic and lifestyle model” was, in addition to model 2, further adjusted for education (low, high), physical activity (>2 h/week, 1 h/
week (regular), 1 h/week (irregular), no sport), alcohol consumption (men: 0–39 g/day, 40 g/day; women: 0–19 g/day, 20 g/day), current smoking
activity (yes, no).
Model 4: The full model (“health status model”) was, in addition to model 3, adjusted for BMI (continuous), hypertension (yes, no), diabetes (yes, no),
dyslipidemia (yes, no).
1 Number of incident stroke cases.
doi:10.1371/journal.pone.0134480.t004
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compared to controls without insomnia. In accordance with our results, Westerlund et al. [12]
observed no association between insomnia symptoms and incident total strokes in their pro-
spective Swedish National March Cohort Study comprising 41,192 adults. These results were
confirmed by a Norwegian study in which insomnia was related to incident non-fatal strokes
in the unadjusted analyses, but not after taking into account all covariates [54]. Besides other
effects resulting from the different geographic, social, and cultural backgrounds of the Asian
and European studies, a further possible reason for these disparate results might be the varying
definitions of insomnia. In the two Asian studies, insomnia was defined as a medical diagnosis
of insomnia according to the clinical modification of the ICD-9. In the present study and in the
two other European studies, however, information about perceived symptoms of insomnia was
obtained by self-report using standardized questionnaires. Further, it may be that only insom-
nia severe enough to attract attention in an inpatient or outpatient setting led to finding an
association with the development of strokes, as in the two Asian studies based on inpatient and
Table 5. Hazard ratios and 95% confidence intervals for the incidence of total strokes (N = 5,974), non-fatal strokes (N = 5,885), and fatal strokes
(N = 5,745) according to self-reported sleep duration (hours per 24 hours), women aged 25 to 74 years.
Women Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Total strokes
Sleep duration
5 (n = 141) 1.40 (0.81–2.40) 0.68 (0.40–1.18) 0.67 (0.39–1.16) 0.68 (0.40–1.18)
6 (n = 511) 1.66 (1.22–2.25) 1.21 (0.89–1.65) 1.19 (0.87–1.62) 1.25 (0.91–1.70)
7–8 (n = 2001) 1.00 1.00 1.00 1.00
9 (n = 361) 1.64 (1.15–2.34) 1.17 (0.82–1.68) 1.17 (0.82–1.67) 1.09 (0.76–1.57)
10 (n = 171) 1.72 (1.05–2.82) 1.09 (0.66–1.79) 1.08 (0.66–1.79) 0.91 (0.55–1.51)
Non-fatal strokes
Sleep duration
5 (n = 101) 1.36 (0.72–2.59) 0.68 (0.36–1.30) 0.67 (0.35–1.28) 0.69 (0.36–1.31)
6 (n = 341) 1.52 (1.05–2.21) 1.13 (0.78–1.65) 1.11 (0.76–1.61) 1.15 (0.79–1.68)
7–8 (n = 1461) 1.00 1.00 1.00 1.00
9 (n = 261) 1.63 (1.08–2.48) 1.20 (0.79–1.83) 1.20 (0.79–1.82) 1.12 (0.74–1.71)
10 (n = 131) 1.81 (1.03–3.20) 1.17 (0.66–2.08) 1.17 (0.66–2.07) 0.98 (0.55–1.74)
Fatal strokes
Sleep duration
5 (n = 41) 1.48 (0.53–4.07) 0.61 (0.22–1.69) 0.60 (0.22–1.67) 0.61 (0.22–1.69)
6 (n = 171) 2.06 (1.19–3.55) 1.43 (0.82–2.47) 1.42 (0.82–2.46) 1.55 (0.89–2.70)
7–8 (n = 541) 1.00 1.00 1.00 1.00
9 (n = 101) 1.70 (0.87–3.35) 1.05 (0.53–2.06) 1.04 (0.52–2.05) 1.00 (0.50–1.98)
10 (n = 41) 1.51 (0.55–4.18) 0.87 (0.31–2.43) 0.88 (0.31–2.45) 0.72 (0.26–2.06)
Abbreviation: HR: hazard ratio, CI: confidence interval, N: Size of the underlying study population with regard to the particular stroke outcome, h: hour.
Model 1: crude model (unadjusted).
Model 2: adjusted for age (continuous) and survey (1, 2, 3, 4).
Model 3: “Socio-demographic and lifestyle model” was, in addition to model 2, further adjusted for education (low, high), physical activity (>2 h/week, 1 h/
week (regular), 1 h/week (irregular), no sport), alcohol consumption (men: 0–39 g/day, 40 g/day; women: 0–19 g/day, 20 g/day), current smoking
activity (yes, no).
Model 4: The full model (“health status model”) was, in addition to model 3, adjusted for BMI (continuous), hypertension (yes, no), diabetes (yes, no),
dyslipidemia (yes, no).
1 Number of incident stroke cases.
doi:10.1371/journal.pone.0134480.t005
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outpatient claims data. Moreover, the database of these studies did not encompass important
possible confounders, including BMI, physical activity, smoking habits, and alcohol consump-
tion [11, 53]. Therefore, it is also conceivable that the restrictions in the confounder adjustment
are responsible for the significant associations between insomnia and strokes in the Asian stud-
ies. This presumption is further supported by a study from Elwood et al. [55] consisting of
1,986 men aged 55 to 69 years, in which frequent insomnia was significantly associated with
incident ischemic strokes. Even in this study, an adjustment for variables like physical activity,
chronic diseases, or medication intake was not performed.
In the Whitehall II Cohort Study, which included 9,098 participants, having unusually rest-
less, disturbed nights was associated with cardiovascular disease mortality only in women [56].
Another study, using data from a French cohort study with 16,989 participants, showed neither
trouble falling asleep nor difficulty staying asleep as significantly related to cardiovascular dis-
ease mortality among men. Because of small numbers of cases in each category for cause-spe-
cific mortality among women in this study, these analyses were realized only for men [57].
Stone and colleagues [58] reported in their Study of Osteoporotic Fractures comprising 8,101
women aged 69 years and over a significantly positive association between self-reported daily
napping and cardiovascular disease mortality. Yet none of these studies performed separate
analyses for stroke-specific mortality.
Regarding sleep duration, von Ruesten et al. [59] observed a relationship between both
short and long daily sleep duration and incident strokes in their European Prospective Investi-
gation into Cancer and Nutrition (EPIC)-Potsdam Study. However, Westerlund et al. [12] and
Amagai et al. [60] found no harmful effects of the amount of sleep on incident strokes; other
studies observed only one exceptional sleep duration category to be predictive of them [29, 61–
63].
Studies with regard to fatal strokes as the outcome of interest are scarce and widely lacking
for the European region [14, 63–67]. In the present study, a U-shaped relationship between
sleep duration and fatal strokes emerged in the models adjusted for age, survey, socio-demo-
graphic, and lifestyle variables among men (models 1–3). However, after additional adjustment
for BMI, hypertension, diabetes, and dyslipidemia (model 4), the association no longer
remained significant. Unfortunately, a responsible interpretation of the data for women was
not possible due to the small number of fatal stroke cases among them. In the literature, the
authors of a recently published study observed a U-shaped relationship between sleep duration
and fatal strokes in their population-based cohort of 63,257 Chinese adults aged 45 to 74 years,
even after adjustment for all covariables [14]. In three other studies, conducted in Japan, Los
Angeles/Hawaii, and China, each comprising more than 95,000 participants, only long sleep
duration was significantly associated with a higher risk of stroke mortality in both sexes [65–
67]. Therefore, it seems that in the present study, maybe the power to detect differences in the
risk of fatal strokes between men with short or long sleep duration compared to those sleeping
7–8 hours daily was merely too low. In a smaller Japanese study from Amagai et al. [64] with
about 11,000 individuals, a sleep duration of 6 hours was related to fatal strokes only in
women. However, in this study, an adjustment for confounders like physical activity or diabe-
tes was lacking. In another recently published study from Leng et al. [63] consisting of 9,692
men and women aged 42 to 81 years from the British population, long sleep duration was asso-
ciated with fatal strokes among women only. A possible explanation for the differing results
regarding the association between long sleep duration and risk of strokes may be the predomi-
nance of older participants in this and the other abovementioned studies. With advancing age,
the probability of experiencing health impairments increases generally [68]. In a study from
Kakizaki et al. [69], the authors observed that the relationship between long sleep duration and
fatal strokes was strongest in participants with limited physical function and poorer self-rated
Relationship between Sleep Disturbances and Strokes
PLOS ONE | DOI:10.1371/journal.pone.0134480 July 31, 2015 11 / 18
general health status. Other possible explanatory approaches could involve, for example, differ-
ent assessments and categorizations of sleep duration variables and covariates, and varying fol-
low-up lengths.
Short sleep duration and early-morning awakening were commonly associated with mood
disorders, painful conditions, and other medical disorders [70–72]. However, insomnia with
objectively measured short sleep duration is suspected to be the most biologically severe pheno-
type of insomnia disorder [73]. In the literature, there is also evidence of a combined effect of
symptoms of insomnia and short sleep duration on the risk of cardiovascular diseases [12, 74].
In the study of Westerlund et al. [12], individuals with short sleep who reported frequent
symptoms of insomnia had the highest risk of overall cardiovascular events, while no risk
increases were found due to either exposure alone (albeit not significant in the full models).
Also in a Dutch population-based cohort study, the authors observed that individuals with
short sleep duration and poor sleep quality had a 63% higher risk of cardiovascular diseases
compared to individuals with 7 hours of daily sleep and good sleep quality, even after adjust-
ments for all covariates [74]. Unfortunately, stroke-specific analyses were not carried out.
Therefore, maybe the simultaneous presence of symptoms of insomnia and short sleep dura-
tion leads to a relationship with a higher propensity for strokes.
Interestingly, in the present study in the analyses additionally adjusted for depressed mood,
in men the positive association between short sleep duration and fatal strokes became signifi-
cant in the fully adjusted models (HR 2.29, 95% CI: 1.13–4.65 versus HR 1.89, 95% CI: 0.96–
3.73) (see S1 Table). These results would suggest that the influence of sleep duration on the risk
of the development of strokes is increased by the additional adjustment for depression. Yet the
depressed mood variable shows a high number of missing values (n = 1,191), which could be
due to the notable sensitivity of questions regarding the psychopathological state of an individ-
ual [75, 76]. Thus, it would be preferable if future research could help to clarify the role of men-
tal health in the association between sleep and risk of strokes.
Furthermore, the association between sleep and strokes seems to be different between men
and women. In the present study and in the literature (e.g., [77]), the proportion of men who
suffered from strokes is higher in comparison to women, and it is known that sex and gender
differences are responsible for different sleep behavior in both sexes [78]. Thus, it would be
desirable that further studies examine the influence of sex- and gender-related aspects on the
relationship between sleep and strokes.
The present study has several limitations and strengths that should be mentioned.
Firstly, the follow-up was not complete for all participants of the respective baseline surveys
(S1-S4), which might have induced a selection bias [79].
Secondly, because the screening question concerning strokes was answered by self-report of
the participants, it is conceivable that not all actual stroke cases were detected. Because some
strokes are only moderately pronounced and there is a decline of stroke symptoms in some
cases (transient ischemic attacks) [80], it may be possible that the number of stroke cases was
underestimated in the present study. However, in our study, during a mean follow-up time of
14 years, 917 first-ever strokes were observed, and the crude incidence rate was roughly compa-
rable with the incidence rates in similar studies [6, 81]. Even so, although the study population
was large, the number of stroke cases divided by sleep duration categories was small, especially
in the nonreference sleep duration categories, and resulted therefore in wide confidence
intervals.
Thirdly, symptoms of insomnia were commonly assessed using established screening tools
like the Insomnia Severity Index [82–84] or the Pittsburgh Sleep Quality Index [85, 86]. In the
present study, symptoms of insomnia were obtained by means of two standardized questions
concerning trouble falling asleep and difficulty staying asleep. These two questions were
Relationship between Sleep Disturbances and Strokes
PLOS ONE | DOI:10.1371/journal.pone.0134480 July 31, 2015 12 / 18
implemented in the initial World Health Organization’s MONICA Augsburg Study in the
years 1984/85 [24, 25] and retained until 2001 for reasons of better comparability of the data.
The above mentioned screening tools had not been published at the time of the first MONICA
Augsburg Study. Nevertheless, the frequency of insomnia symptoms in the present study and
in the literature is quite similar [15]. A further limitation of this study is the lack of information
about the respective causes of insomnia symptoms, whether the symptoms were acute or
chronic, and about possible changes in insomnia symptoms and sleep duration during the
study period, because in the present study the current sleep-related issues were assessed only in
the respective baseline surveys. Although some prospective studies indicate that symptoms of
insomnia often tend to be persistent and become chronic [87, 88], a large variability can also be
recorded [89, 90]. Therefore, it is of particular interest that future studies perform repeated
assessments of sleep issues in short intervals during the follow-up period to take into consider-
ation the natural course of insomnia and sleep duration over time [89]. According to the litera-
ture [91], self-reported sleep duration is moderately correlated with sleep duration measured
by an actigraph. Yet the authors found that subjective reports of sleep duration were biased due
to systematic overreporting by the participants. Additionally, we asked the participants only to
report the frequency of insomnia symptoms. The literature reports a considerable interindivid-
ual variability with regard to the susceptibility of individuals to the effects of sleep disturbances
[18]. Therefore, the individual impact of symptoms of insomnia or exceptional sleep duration
could also be connected to the incidence of strokes.
Finally, we have included a wide range of covariables in the analyses, such as socio-demo-
graphic aspects, health status, several diseases, and medical history. Regrettably, in our study
there is no information available on whether the participants suffer from sleep apnea. Sleep
apnea occurs predominantly in men [92] and is commonly associated with cardiovascular con-
ditions, like hypertension [93]. One assumption is that patients suffering from sleep apnea
compensate for the disruption of sleep accompanying this syndrome by spending a longer
period of time in bed or by long sleep duration [22, 94]. Therefore, it may be possible that the
incidence of strokes is associated with aspects related to sleep apnea, and not with the tendency
of long sleep duration by itself [22]. Further research should explore these issues.
The most important strengths of the present study are the prospective study design with
high overall responses and a long follow-up length. Further positive considerations are the
large population-representative database including the availability of information about several
sleep aspects, stroke outcomes, and potential covariables, which enabled statistical analyses
with complex multivariable methods. A further advantage is the physician-validated diagnosis
of strokes. High-quality standards and controls [25, 26] also strengthened the results of the
MONICA/KORA Augsburg Cohort Study.
Conclusion
In conclusion, the results suggest that trouble falling asleep and difficulty staying asleep are not
associated with incident total strokes, non-fatal strokes, or fatal strokes in either sex. There is
an increased risk especially for fatal strokes in men with short and long sleep duration, albeit
insignificant. Further research should explore the role of a combined effect of symptoms of
insomnia and short sleep duration in association with incident strokes taking into account the
sex- and gender-specific particularities regarding this issue.
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